Skip to Content

454 WATSON (Gemfibrozil 600 mg)

Pill imprint 454 WATSON has been identified as Gemfibrozil 600 mg.

Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Gemfibrozil 600 mg is not a controlled substance under the Controlled Substance Act (CSA).

Gemfibrozil 600 mg 454 WATSON
Gemfibrozil 600 mg 454 WATSON
Gemfibrozil
Imprint:
454 WATSON
Strength:
600 mg
Color:
Orange
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0454
Inactive Ingredients:
calcium stearate
silicon dioxide colloidal
croscarmellose sodium
FD&C Red No. 40 Aluminium Lake
FD&C Yellow No. 6 Aluminum Lake
hydroxypropyl cellulose
microcrystalline cellulose
polyethylene glycol
polysorbate 80
pregelatinized starch
titanium dioxide

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide